Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10727211rdf:typepubmed:Citationlld:pubmed
pubmed-article:10727211lifeskim:mentionsumls-concept:C0037382lld:lifeskim
pubmed-article:10727211lifeskim:mentionsumls-concept:C0064528lld:lifeskim
pubmed-article:10727211lifeskim:mentionsumls-concept:C0763396lld:lifeskim
pubmed-article:10727211lifeskim:mentionsumls-concept:C0205245lld:lifeskim
pubmed-article:10727211lifeskim:mentionsumls-concept:C0009017lld:lifeskim
pubmed-article:10727211lifeskim:mentionsumls-concept:C1151838lld:lifeskim
pubmed-article:10727211lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:10727211pubmed:issue12lld:pubmed
pubmed-article:10727211pubmed:dateCreated2000-5-4lld:pubmed
pubmed-article:10727211pubmed:abstractTextWe previously purified apoxin I, an apoptosis-inducing factor with L-amino acid oxidase (LAO) activity, from Western diamondback rattlesnake venom. To determine the primary structure of apoxin I, we cloned its cDNA. The amino acid sequence showed that apoxin I has an FAD binding domain and shares homology with L-amino acid oxidase (LAO) from Neurospora crassa, human monoamine oxidase B, and mouse interleukin 4-induced F1G1 protein. The full-length apoxin I has an N-terminal signal sequence that is processed in mature apoxin I in venom. When the apoxin I gene was transfected into human 293T cells, the recombinant protein was expressed in the cells, and a significant amount of apoxin I was secreted into the medium. The secreted recombinant apoxin I protein showed LAO and apoptosis-inducing activity, but the recombinant protein in the cells did not, suggesting that maturation and secretion of the apoxin I protein is needed for its activity. Treating the transfected cells with tunicamycin inhibited the secretion and LAO activity of the recombinant apoxin I. In addition, deleting the amino-terminal region flanking the signal sequence, the FAD-binding domain and the carboxy-terminal region abolished the secretion and LAO activity of the recombinant proteins. These results indicate that in order for apoxin I to become active, these regions and posttranslational modification, such as N-glycosylation, are required.lld:pubmed
pubmed-article:10727211pubmed:languageenglld:pubmed
pubmed-article:10727211pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10727211pubmed:citationSubsetIMlld:pubmed
pubmed-article:10727211pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10727211pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10727211pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10727211pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10727211pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10727211pubmed:statusMEDLINElld:pubmed
pubmed-article:10727211pubmed:monthMarlld:pubmed
pubmed-article:10727211pubmed:issn0006-2960lld:pubmed
pubmed-article:10727211pubmed:authorpubmed-author:TsuruoTTlld:pubmed
pubmed-article:10727211pubmed:authorpubmed-author:YamamotoKKlld:pubmed
pubmed-article:10727211pubmed:authorpubmed-author:YamaneKKlld:pubmed
pubmed-article:10727211pubmed:authorpubmed-author:FoxJ WJWlld:pubmed
pubmed-article:10727211pubmed:authorpubmed-author:ToriiSSlld:pubmed
pubmed-article:10727211pubmed:authorpubmed-author:NaitoMMlld:pubmed
pubmed-article:10727211pubmed:authorpubmed-author:HageJJlld:pubmed
pubmed-article:10727211pubmed:authorpubmed-author:MashimaTTlld:pubmed
pubmed-article:10727211pubmed:issnTypePrintlld:pubmed
pubmed-article:10727211pubmed:day28lld:pubmed
pubmed-article:10727211pubmed:volume39lld:pubmed
pubmed-article:10727211pubmed:ownerNLMlld:pubmed
pubmed-article:10727211pubmed:authorsCompleteYlld:pubmed
pubmed-article:10727211pubmed:pagination3197-205lld:pubmed
pubmed-article:10727211pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10727211pubmed:meshHeadingpubmed-meshheading:10727211...lld:pubmed
pubmed-article:10727211pubmed:meshHeadingpubmed-meshheading:10727211...lld:pubmed
pubmed-article:10727211pubmed:meshHeadingpubmed-meshheading:10727211...lld:pubmed
pubmed-article:10727211pubmed:meshHeadingpubmed-meshheading:10727211...lld:pubmed
pubmed-article:10727211pubmed:meshHeadingpubmed-meshheading:10727211...lld:pubmed
pubmed-article:10727211pubmed:meshHeadingpubmed-meshheading:10727211...lld:pubmed
pubmed-article:10727211pubmed:meshHeadingpubmed-meshheading:10727211...lld:pubmed
pubmed-article:10727211pubmed:meshHeadingpubmed-meshheading:10727211...lld:pubmed
pubmed-article:10727211pubmed:meshHeadingpubmed-meshheading:10727211...lld:pubmed
pubmed-article:10727211pubmed:meshHeadingpubmed-meshheading:10727211...lld:pubmed
pubmed-article:10727211pubmed:meshHeadingpubmed-meshheading:10727211...lld:pubmed
pubmed-article:10727211pubmed:meshHeadingpubmed-meshheading:10727211...lld:pubmed
pubmed-article:10727211pubmed:meshHeadingpubmed-meshheading:10727211...lld:pubmed
pubmed-article:10727211pubmed:meshHeadingpubmed-meshheading:10727211...lld:pubmed
pubmed-article:10727211pubmed:meshHeadingpubmed-meshheading:10727211...lld:pubmed
pubmed-article:10727211pubmed:meshHeadingpubmed-meshheading:10727211...lld:pubmed
pubmed-article:10727211pubmed:year2000lld:pubmed
pubmed-article:10727211pubmed:articleTitleMolecular cloning and functional analysis of apoxin I, a snake venom-derived apoptosis-inducing factor with L-amino acid oxidase activity.lld:pubmed
pubmed-article:10727211pubmed:affiliationInstitute of Molecular and Cellular Biosciences, The University of Tokyo, Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan.lld:pubmed
pubmed-article:10727211pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10727211pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10727211lld:pubmed